| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.2M | -1.4% |
| Cost of Revenue | $18.9M | +6.7% |
| Gross Profit | $14.3M | -10.4% |
| R&D Expense | $10.4M | +65.7% |
| SG&A Expense | $27.8M | +58.6% |
| Operating Income | -$24.0M | -198.5% |
| Interest Expense | $7K | -98.3% |
| Pre-tax Income | -$20.2M | -1298.2% |
| Income Tax | $31K | +143.7% |
| Net Income | -$20.2M | -1251.5% |
| EPS (Basic) | -$0.38 | -1050.0% |
| EPS (Diluted) | -$0.38 | -1050.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.6M | -61.6% |
| Accounts Receivable | $1.6M | +17.1% |
| Inventory | $1.3M | +41.0% |
| Current Assets | $49.8M | -42.5% |
| Total Assets | $79.5M | -15.1% |
| Current Liabilities | $10.0M | +63.5% |
| Total Liabilities | $11.7M | +34.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.6M | -155.3% |
| Capital Expenditures | $10.1M | +155.5% |
| Investing Cash Flow | -$28.8M | -626.2% |
| Financing Cash Flow | $339K | -99.6% |
| Free Cash Flow | -$30.7M | -155.4% |
| Stockholders' Equity |
| $67.8M |
| -20.2% |